Skip to main content
. 2021 Dec 1;53(3):956–967. doi: 10.1161/STROKEAHA.121.035216

Figure 4.

Figure 4.

Dosage (total speech and language therapy [SLT] hours) and associated gains from baseline (mean; 95% CI). Overall language (A): Western Aphasia Battery–Aphasia Quotient (0–100); 480 individual participant data (IPD; 11 randomized controlled trials [RCTs]); functional communication (B): Aachen Aphasia Test–Spontaneous Speech Communication (AAT-SSC; 0–5); 524 IPD (14 RCTs); auditory comprehension (C): Aachen Aphasia Test (AAT) Token Test (0–50); 540 IPD (16 RCTs); naming (D): Boston Naming Test (BNT; 0–60); 385 IPD (13 RCTs).